TNF Pharma Presents Oral TNF-Alpha Inhibitor at BGS Society Meeting
16 Apr 2025 //
BUSINESSWIRE
TNF Pharmaceuticals Presents Oral TNF-Alpha Inhibitor at Conference
17 Mar 2025 //
BUSINESSWIRE
TNF Pharmaceuticals Investor Conference Call & Webcast March 6
05 Mar 2025 //
BUSINESSWIRE
TNF Pharma Initiates Ph 2b Trial of First Oral TNF-Alpha Inhibitor
25 Feb 2025 //
BUSINESSWIRE
TNF Pharma Launches Study On Muscle Mass In GLP-1 Weight Loss
29 Jan 2025 //
BUSINESSWIRE
TNF Pharma Shows Promising Results For Clinical Trial Growth
15 Jan 2025 //
BUSINESSWIRE
TNF Pharma Launches Trial on Lead Candidate in Sarcopenia/Frailty
19 Dec 2024 //
BUSINESSWIRE
TNF Presents Significant Results for Sarcopenia Treatment
09 Dec 2024 //
BUSINESSWIRE